MacKie, R. and Bray, C.A. (2004) Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma. British Journal of Cancer, 90(4), pp. 770-772. (doi: 10.1038/sj.bjc.6601595)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1038/sj.bjc.6601595
Abstract
A total of 206 women were followed for a minimum of 5 years after primary melanoma surgery to establish if hormone replacement therapy (HRT) adversely affected prognosis. In all, 123 had no HRT and 22 have died of melanoma; 83 had HRT for varying periods and one has died of melanoma. After controlling for known prognostic factors, we conclude that HRT after melanoma does not adversely affect prognosis.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Kelly, Mrs Caroline and MacKie, Prof Rona |
Authors: | MacKie, R., and Bray, C.A. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | British Journal of Cancer |
Journal Abbr.: | BJC |
ISSN: | 0007-0920 |
ISSN (Online): | 1532-1827 |
University Staff: Request a correction | Enlighten Editors: Update this record